Browse
Browse
Home
People
Organizations
Research
Events
Capability Map
Antiviral Therapy
Journal
Overview
Identity
Overview
Publication Venue For
Commentary: John C. Martin (1951-2021).
. 27:13596535211067895.
2022
Commentary: Development of Therapeutics for Congenital Cytomegalovirus Infection
. 27.
2022
Evolution of HIV-1 drug resistance after virological failure of first-line antiretroviral therapy in Lusaka, Zambia
. 24:291-300.
2019
Longitudinal study of falls among HIV-infected and uninfected women: The role of cognition
. 23:179-190.
2018
Patterns of efavirenz use as first-line antiretroviral therapy in the United States: 1999-2015
. 23:363-372.
2018
Tenofovir disoproxil fumarate appears to disrupt the relationship of Vitamin D and parathyroid hormone
. 23:623-6928.
2018
Falls among middle-aged women in the Women's Interagency HIV Study
. 21:697-706.
2016
Sex differences in overall and cause-specific mortality among HIV-infected adults on antiretroviral therapy in Europe, Canada and the US
. 20:21-28.
2015
Single dose peramivir for the treatment of acute seasonal influenza: Integrated analysis of efficacy and safety from two placebo-controlled trials
. 20:709-719.
2015
Vitamin D3 supplementation increases fibroblast growth factor-23 in HIV-infected youths treated with tenofovir disoproxil fumarate
. 19:613-618.
2014
The 'Red Queen' dilemma - Running to stay in the same place: Reflections on the evolutionary vector of HBV in humans
. 18:489-496.
2013
Late diagnosis, delayed presentation and late presentation in HIV: Proposed definitions, methodological considerations and health implications
. 18:17-23.
2013
HIV infection and obesity: Where did all the wasting go?
. 17:1281-1289.
2012
Risk factors for vitamin D deficiency and relationship with cardiac biomarkers, inflammation and immune restoration in HIV-infected youth
. 17:1069-1078.
2012
Vitamin D is linked to carotid intima-media thickness and immune reconstitution in HIV-positive individuals
. 16:555-563.
2011
Prognostic importance of anaemia in HIV type-1-infected patients starting antiretroviral therapy: Collaborative analysis of prospective cohort studies
. 13:959-967.
2008
Intracellular nucleoside triphosphate concentrations in HIV-infected patients on dual nucleoside reverse transcriptase inhibitor therapy
. 12:981-986.
2007
A randomized study of antiviral medication switch at lower- versus higher-switch thresholds: AIDS clinical trials group study A5115
. 12:531-541.
2007
Design issues in initial HIV-treatment trials: Focus on ACTG A5095
. 11:751-760.
2006
Current status and future prospects of therapeutic drug monitoring and applied clinical pharmacology in antiretroviral therapy
. 10:375-392.
2005
Therapeutic drug monitoring and drug-drug interactions involving antiretroviral drugs
. 10:469-477.
2005
Polyphenotypic expression of mitochondrial toxicity caused by nucleoside reverse transcriptase inhibitors
. 8:253-257.
2003
Single-dose pharmacokinetics of enteric-coated didanosine in HIV-infected children
. 7:267-270.
2002
A dose-ranging study to evaluate the antiretroviral activity and safety of amprenavir alone and in combination with abacavir in HIV-infected adults with limited antiretroviral experience
. 6:89-96.
2001
The management of herpesvirus infections in individuals with human immunodeficiency virus or AIDS
. 2:25-28.
1997
Identity
International Standard Serial Number (issn)
1359-6535
Electronic International Standard Serial Number (eissn)
2040-2058